INTRAVESICAL NGF ANTISENSE THERAPY USING LIPID NANOPARTICLE FOR INTERSTITIAL CYSTITIS

$1,644,053FY2012Department of the ArmyDOD

Lipella Pharmaceuticals Inc

Investigators

View source on USAspending →